Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2015

01-12-2015 | Endocrine Tumors

Incidental and Intentional Medicine Achieve Similar Results in Primary Hyperaldosteronism

Authors: Lindsay E. Kuo, MD, MBA, Heather Wachtel, MD, Robert E. Roses, MD, Douglas L. Fraker, MD, Rachel R. Kelz, MD, MSCE

Published in: Annals of Surgical Oncology | Special Issue 3/2015

Login to get access

Abstract

Background

Primary hyperaldosteronism is a common cause of hypertension, with significant cardiovascular, renal, and metabolic sequelae. Delayed diagnosis of primary hyperaldosteronism can lead to severe disease and lower cure rates after adrenalectomy. This study investigated the presentation and outcomes of patients who had primary hyperaldosteronism diagnosed after incidental discovery of an adrenal mass.

Methods

A retrospective cohort study investigated patients receiving adrenalectomy for primary hyperaldosteronism at the authors’ institution from 2001 to 2014. Patients were classified as nonincidental if the aldosteronoma was identified on imaging performed for a hypertension or hypokalemia workup or after a biochemical diagnosis or as incidental if the aldosteronoma was identified on imaging performed for any other reason. Nonincidental and incidental patients were compared in terms of patient demographics, clinical history, preoperative test results, surgical pathology findings, and postoperative course.

Results

The study included 210 patients, 17 (8.1 %) of whom were incidental. At the time of surgical evaluation, 88 % of the incidental patients met the criteria for primary hyperaldosteronism screening based on hypokalemia or the degree of hypertension. The incidental patients were younger than the nonincidental patients, but the two groups were otherwise demographically and clinically similar. The incidental patients had larger aldosteronomas than the nonincidental patients. The nonincidental and incidental patients had similar rates of postoperative cure and failure.

Conclusions

Nonincidental and incidental patients have comparable disease severity before surgical evaluation and similar rates of postoperative cure. Increased adherence to guidelines for screening of primary hyperaldosteronism will lead to a more timely diagnosis for all patients and a higher potential for surgical cure.
Literature
1.
go back to reference Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266–81.PubMedCrossRef Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266–81.PubMedCrossRef
2.
go back to reference Zieger MA, Thompson GB, Duh Q-Y, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009;15(Suppl 1):1–20.CrossRef Zieger MA, Thompson GB, Duh Q-Y, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009;15(Suppl 1):1–20.CrossRef
3.
go back to reference Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273–85.PubMedCrossRef Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273–85.PubMedCrossRef
4.
go back to reference Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemia nd normockelmic primary aldosteronism: results of the German Conn’s Registry. J Clin Endocrinol Metab. 2009;94:1125–30.PubMedCrossRef Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemia nd normockelmic primary aldosteronism: results of the German Conn’s Registry. J Clin Endocrinol Metab. 2009;94:1125–30.PubMedCrossRef
5.
go back to reference Savard S, Amar L, Plouin P-F, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. J Hypertens. 2013;62:331–6.CrossRef Savard S, Amar L, Plouin P-F, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. J Hypertens. 2013;62:331–6.CrossRef
6.
go back to reference Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, Mourad J-J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243–48.PubMedCrossRef Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, Mourad J-J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243–48.PubMedCrossRef
7.
go back to reference Rossi G-P, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrin Metab. 2008;19:88–90.CrossRef Rossi G-P, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrin Metab. 2008;19:88–90.CrossRef
8.
go back to reference Turchi F, Ronconi V, DiTizio V, Ceccoli L, Boscaro M, Giacchetti G. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. Nutr Metab Cardiovasc. 2013;24:476–82.CrossRef Turchi F, Ronconi V, DiTizio V, Ceccoli L, Boscaro M, Giacchetti G. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. Nutr Metab Cardiovasc. 2013;24:476–82.CrossRef
9.
go back to reference Zarnegar R, Young WF, Lee J, et al. The aldosteronoma resolution score: predicting complete resolution of hyperension after adrenalectomy for aldosteronoma. Ann Surg. 2008;247:511–8.PubMedCrossRef Zarnegar R, Young WF, Lee J, et al. The aldosteronoma resolution score: predicting complete resolution of hyperension after adrenalectomy for aldosteronoma. Ann Surg. 2008;247:511–8.PubMedCrossRef
10.
go back to reference Utsumi T, Kamiya N, Endo T, et al. Development of a novel nomogram to predict hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg. 2014;38:2640–4.PubMedCrossRef Utsumi T, Kamiya N, Endo T, et al. Development of a novel nomogram to predict hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg. 2014;38:2640–4.PubMedCrossRef
11.
go back to reference Wachtel H, Cerullo I, Bartlett EK, et al. Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism. Surgery. 2014;156:1394–403.PubMedCrossRef Wachtel H, Cerullo I, Bartlett EK, et al. Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism. Surgery. 2014;156:1394–403.PubMedCrossRef
12.
go back to reference Wachtel H, Cerullo I, Bartlett EK, et al. Clinicopathologic characteristics of incidentally identified pheochromocytoma. Ann Surg Oncol. 2015;22:132–8.PubMedCrossRef Wachtel H, Cerullo I, Bartlett EK, et al. Clinicopathologic characteristics of incidentally identified pheochromocytoma. Ann Surg Oncol. 2015;22:132–8.PubMedCrossRef
13.
go back to reference Grogan RH, Mitmaker E, Vriens MR, et al. Adrenal incidentaloma: does an adequate workup rule out surprises? Surgery. 2010;148:392–7.PubMedCrossRef Grogan RH, Mitmaker E, Vriens MR, et al. Adrenal incidentaloma: does an adequate workup rule out surprises? Surgery. 2010;148:392–7.PubMedCrossRef
14.
go back to reference Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab. 2000;85:637–44.PubMed Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab. 2000;85:637–44.PubMed
15.
go back to reference AlFehaily M, Duh Q-Y. Clinical manifestation of aldosteronoma. Surg Clin North Am. 2004;84:887–905.PubMedCrossRef AlFehaily M, Duh Q-Y. Clinical manifestation of aldosteronoma. Surg Clin North Am. 2004;84:887–905.PubMedCrossRef
16.
go back to reference Schirpenbach C, Reincke M. Screening for primary aldosteronism. Best Pract Res Clin Endocrinol & Metab. 2006;20:369–84.CrossRef Schirpenbach C, Reincke M. Screening for primary aldosteronism. Best Pract Res Clin Endocrinol & Metab. 2006;20:369–84.CrossRef
17.
go back to reference Loy CT, Irwig L. Accuracy of diagnostic tests with and without clinical information. JAMA. 2004;292:1602–9.PubMedCrossRef Loy CT, Irwig L. Accuracy of diagnostic tests with and without clinical information. JAMA. 2004;292:1602–9.PubMedCrossRef
18.
go back to reference Cawood T, Hunt P, O’Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentaloma has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol. 2009;161:513–27.PubMedCrossRef Cawood T, Hunt P, O’Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentaloma has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol. 2009;161:513–27.PubMedCrossRef
19.
go back to reference Boland GWL, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and imaging characterization. Radiology. 2008;249:756–65.PubMedCrossRef Boland GWL, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and imaging characterization. Radiology. 2008;249:756–65.PubMedCrossRef
20.
go back to reference Stowasser M, Gordon RD, Gunasekera T, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after “nonselective” screening of hypertensive patients. J Hypertens. 2003;21:2149–57.PubMedCrossRef Stowasser M, Gordon RD, Gunasekera T, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after “nonselective” screening of hypertensive patients. J Hypertens. 2003;21:2149–57.PubMedCrossRef
21.
go back to reference Giacchetti G, Ronconi V, Rilli S, Guerrierri M, Turchi F, Boscaro M. Small tumor size as favorable prognostic factor after adrenalectomy in Conn’s adenoma. Eur J Endocrinol. 2009;160:639–46.PubMedCrossRef Giacchetti G, Ronconi V, Rilli S, Guerrierri M, Turchi F, Boscaro M. Small tumor size as favorable prognostic factor after adrenalectomy in Conn’s adenoma. Eur J Endocrinol. 2009;160:639–46.PubMedCrossRef
22.
go back to reference Mulatero P, Stowasser M, Loh K-C, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045–50.PubMedCrossRef Mulatero P, Stowasser M, Loh K-C, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045–50.PubMedCrossRef
23.
go back to reference Gordon RD, Stowasser M, Rutherford JC. Primary aldosteronism: are we diagnosis and operating on too few patients? World J Surg. 2001;25:941–7.PubMedCrossRef Gordon RD, Stowasser M, Rutherford JC. Primary aldosteronism: are we diagnosis and operating on too few patients? World J Surg. 2001;25:941–7.PubMedCrossRef
24.
go back to reference Kaplan NM. The current epidemic of primary aldosteronsim: causes and consequences. J Hypertens. 2004;22:863–9.PubMedCrossRef Kaplan NM. The current epidemic of primary aldosteronsim: causes and consequences. J Hypertens. 2004;22:863–9.PubMedCrossRef
25.
go back to reference Schwartz GL. Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness. Endocrinol Metab Clin North Am. 2011;40:279–94.PubMedPubMedCentralCrossRef Schwartz GL. Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness. Endocrinol Metab Clin North Am. 2011;40:279–94.PubMedPubMedCentralCrossRef
26.
go back to reference Douma S, Petidis K, Doumas M, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371:1921–6.PubMedCrossRef Douma S, Petidis K, Doumas M, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371:1921–6.PubMedCrossRef
27.
go back to reference Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–300.PubMedCrossRef Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–300.PubMedCrossRef
28.
Metadata
Title
Incidental and Intentional Medicine Achieve Similar Results in Primary Hyperaldosteronism
Authors
Lindsay E. Kuo, MD, MBA
Heather Wachtel, MD
Robert E. Roses, MD
Douglas L. Fraker, MD
Rachel R. Kelz, MD, MSCE
Publication date
01-12-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4729-3

Other articles of this Special Issue 3/2015

Annals of Surgical Oncology 3/2015 Go to the issue